EVAN CRESSMAN
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant MASSAPEQUA, NY NPI 1548955503
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$476.79
- Category: General Payments
- Program years: PY2023–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $336.20 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $198.01 | 2 |
| Food and Beverage | $138.19 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $99.01 | 1 |
| AVEO Pharmaceuticals, Inc. | $99.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $71.40 | 3 |
| Gilead Sciences, Inc. | $41.07 | 2 |
| ABBVIE INC. | $25.72 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086753337 | Novartis Pharmaceuticals Corporation | $23.77 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086753355 | Novartis Pharmaceuticals Corporation | $26.17 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086753365 | Novartis Pharmaceuticals Corporation | $21.46 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104482494 | AstraZeneca Pharmaceuticals LP | $99.01 | 01/08/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1106966651 | ABBVIE INC. | $25.72 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133712577 | Gilead Sciences, Inc. | $18.75 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133712579 | Gilead Sciences, Inc. | $22.32 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143492541 | Aveo Pharmaceuticals, Inc. | $99.00 | 05/15/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.